It’s an illustration of the possibility of a continuum envisaged by Berg – of one’s passions, interests and personality surviving, not being sublimated by, parenthood. The solution to the ...
"We are extremely pleased that the FDA granted Fast Track Designation to CUSP06," said Eric Slosberg, PhD, Chief Development Officer of OnCusp Therapeutics. "The early results from our Phase 1 trial ...